For the first time, the U.S. Food and Drug Administration (FDA) has approved the use of a ketamine-like drug as a stand-alone therapy for adults with treatment-resistant depression (TRD).

To address esketamine's side effects, the FDA will require that the drug be given in the presence of a clinician so patients can be monitored for a few hours. "Because of [safety] concerns ...

The FDA has approved Janssen’s antidepressant ... who have cycled through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster for Janssen ...

Enter psychedelics like ketamine, psilocybin, and MDMA, which are being explored as tools to access and process these buried ...

Janssen’s potential depression treatment made from esketamine – a version of the substance notoriously used illegally as a party drug – is to be reviewed by advisers to the FDA at a crunch ...

Alert FDA OKs Esketamine Nasal Spray Monotherapy for Depression The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not responded ...

In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...

This is because the Food and Drug Administration (FDA) only approves the drug ketamine for use in general anesthetics. However, Medicare may cover the drug Spravato, which contains esketamine.

It wasn’t long before a new word was bandied about: breakthrough. In 2013, the U.S. Food and Drug Administration (FDA) granted esketamine a “Breakthrough Therapy Designation” to accelerate studies of ...

There is hope for your symptoms. The clinic also offer the FDA approved Spravato (Esketamine) for treatment resistant depression, anxiety, and PTSD. Call for inquiries. Immediate appointment times ...